Lanting Intelligent Medicine
兰丁股份
elsewhere's corpus does not cover Lanting Intelligent Medicine as a subject — the only material found is a single relation noting that Dalton Venture invested in the company, and that Lanting was selected as a national-level "little giant" enterprise as early as 2021 . No entity card or document chunks describe its business, founding, team, or operations.
AI-generated — may contain errors, please verify.
Coverage
From Early Innovation to Industry Recognition: A Map of Dalton Venture's Specialized and Innovative Portfolio Companies
"Specialized, refined, distinctive, and innovative" enterprises are increasingly becoming a key benchmark for assessing the growth quality of China's technology and innovation companies. It represents not only a company's technical strength, innovation capability, and growth potential in niche sectors, but also serves as external validation from the industrial system of the value of outstanding SMEs. Recently, **Xuanyu Medical**, a **Dalton Venture family company**, was once again named to **Shanghai's second batch of 2026 specialized, refined, distinctive, and innovative SMEs. This marks Xuanyu Medical's continued recognition following its 2023 selection.
Steady Steps Toward Renewal, Momentum Into Waves | DTX 2025 Annual Review
Those who walk deeper into the cycle always spot the next beam of light.
Riding the Wind, Breaking Boundaries — Tides Surge in Hong Kong | Dalton Venture 2025 CEO Summit Successfully Concludes
At the intersection of technological revolution and industrial transformation, what should be the starting point for the globalization of the life sciences industry? Where should mainland Chinese healthcare innovators set their first foothold for overseas expansion? Against a backdrop of intensifying international competition and sustained policy tailwinds, is Hong Kong — a city that blends international perspective with institutional advantages — emerging as the bridge for tech ventures to reach the world?
Over 50,000 Cases in a Single Day! Inside the Speed of Landing AI's Cervical Cancer Screening | Dalton Venture Family
Landing Med aims to automate, digitize, and scale cytological pathology diagnosis through AI-powered, cloud-based diagnostic technology — enabling intelligent, networked, and standardized early detection of high-incidence tumors.
